baber/WOPTO huggingface dataset:
Patent NZ-318109-A (NZ)
Title: Aseptic transfer unsealed pharmaceutical containers in chamber flooded with sterile gas
Inventor: OLSSON BERT-AKE
IPC: A61L2/20
Filed: 1996-09-06
Abstract: A transfer device for aseptic and automatic transfer of filled, unsealed pharmaceutical containers (2) which comprises a transport vehicle (11) with a vertically adjustable platform (12) supporting a transportable and sealable chamber (1). The chamber (1) comprises an upper part (8) provided with a protective-gas inlet (7), a lower part (9) provided with a frame (13) for supporting the containers (2), a closable opening (14), and an intermediate, substantially horizontal flow distributor (10).
Patent NZ-321268-A (NZ)
Title: Apparatus and methods for signal strength measurement in a wireless communication system
Inventor: RAITH ALEX KRISTER
IPC: H04W36/08
Filed: 1996-10-18
Abstract: Methods and devices for measuring signal strengths by mobile stations in a wireless communication system are described. More particularly, while transmitting and receiving on a channel, signal strength measurements may be required. For instance, the received signal strength of broadcast information slots at the beginning of a superframe may be measured at predetermined times for several carriers. However, the mobile station may be busy performing information reception or transmission tasks. According to one exemplary embodiment, the signal strength measurements may be delayed when the mobile is transmitting and receiving on a channel, and then more frequent signal strength measurements may be made when there is no communication. In other words, the signal strength measurements do not have to occur uniformly in time, but may be more frequently performed if they have been delayed. Alternatively, the mobile station can "steal" one or more time slots to perform the signal strength measurements by ignoring its tasks of receiving and/or transmitting information.
Patent NZ-331567-A (NZ)
Title: Carcass clamp for holding hind legs of sheep during aitch boning
Inventor: PITT ARTHUR
IPC: A22C17/02
Filed: 1999-08-25
Abstract: his carcass clamp includes a base member insertable into a cavity of a carcass, a clamping element to fix the carcass to the base member and a sensing device to sense the location of the base member in the cavity.
Patent NZ-332222-A (NZ)
Title: Particle deposition apparatus
Inventor: SUN HOI CHEONG STEVE
IPC: H02N13/00
Filed: 1997-04-09
Abstract: An electrostatic chuck 910 has a conductive layer 920, with a dielectric layer 930 on top of it.  An upper conductive layer 940 may protrude outward form the dielectric layer, or may be embossed into it.  The chuck is used for electrostatically attracting charged particles, which are supplied from a dispenser adjacent to the chuck.  A sensor (not shown) measures the amount of charged particles adhering to the chuck.  The chuck is used to deposit particles of a pharmaceutical onto a substrate, the substrate being attached to the chuck.
Patent NZ-337000-A (NZ)
Title: Applying anthraquinone compound with N-phosphonomethylglycine to plant foliage with a concentration of at least 0.25 g/ha
Inventor: BRINKER RONALD J
IPC: A01N41/04
Filed: 1998-01-30
Abstract: Compositions of exogenous chemicals, particularly phloem-mobile exogenous chemicals, are provided for treatment of plants, wherein the composition comprises the exogenous chemical and an enhancing agent consisting of an anthraquinone or substituted anthraquinone. Specific compositions contain herbicides, particularly N-phosphonomethylglycine and herbicidal derivatives thereof, i.e., glyphosate. The compositions exhibit enhanced effectiveness compared to compositions in which the enhancing agent is not present. Also provided are processes for applying an exogenous chemical with an anthraquinone or substituted anthraquinone enhancing agent to achieve enhanced biological effectiveness. Wherein; R1-R8 are independently hydrogen, alkyl groups having 1-30 carbon atoms, alkenyl groups having 2-30 carbon atoms, alkoxy groups having from 1-30 carbon atoms, halogen, amino groups, alkylamino groups having 1-30 carbon atoms, hydroxy groups, hydroxyalkyl groups having 1-30 carbon atoms, cyano groups, nitro groups, haloalkyl group from 1-30 carbon atoms, carboxy groups or aryl groups having 1-30 carbon atoms.
Patent NZ-337074-A (NZ)
Title: An apparatus and a method for producing an extruded hollow plastic section to be supported and guided by the extrusion apparatus
Inventor: VISSCHER JAN
IPC: B29C48/32
Filed: 1998-02-06
Abstract: Apparatus and method for producing a hollow plastic section (5). The apparatus comprises an extruder (1) which is provided with a die (2), which extrudes substantially in the horizontal direction, for extruding a hollow section (5) made of thermoplastic material. The die (2) has an inner mandrel which forms the cavity in the section, a first sealing plug (12) and a second sealing plug (13), which sealing plugs (12, 13) are situated at a distance from one another downstream of the inner mandrel (3) and are attached to the inner mandrel (3), and which sealing plugs (12, 13) are designed, during operation of the apparatus, to lie in the hollow section, such that they are sealed against the section (5), so that the sealing plugs (12, 13) and the section (5) delimit a compartment (20, 21) in the cavity of the section (5), means (22a, 22b, 23a, 23b) for filling the compartment (20, 21) with a liquid, so that a compartment which is filled with liquid during operation of the apparatus is created. The apparatus is designed in such a manner that the compartment (20, 21) which is filled with liquid has a highest point, and in that the apparatus comprises vent (27, 28) means for discharging from the compartment (20, 21), which is filled with liquid, gas or vapour which collects at the highest point of the compartment.
Patent NZ-500533-A (NZ)
Title: Osteoblast-promoting pharmaceutical composition comprising an alkanoyl L-carnitine compound and DHEA or DHEA-S
Inventor: CAVAZZA CLAUDIO
IPC: A61K31/565
Filed: 1998-04-03
Abstract: Lower alkanoyl L-carnitines or the pharmacologically acceptable salts thereof, may be used in combination with dehydroepiandrosterone (DHEA) or dehydroepiandrosterone sulphate (DHEA-S) for promoting the formation of bone callus and for the healing of fractures.
Patent NZ-505992-A (NZ)
Title: Process for refining solid precious metal containing concentrate
Inventor: CRAIG DEBORAH CAROL
IPC: C22B5/12
Filed: 2000-07-26
Abstract: A method for refining a solid precious metal-containing concentrate comprising the following steps: 1. a high temperature treatment of the concentrate with hydrogen chloride gas to yield a first residue, 2. an optional treatment of the first residue with chlorine gas to yield a second residue, 3. a high temperature treatment of the first or second residue with oxygen to yield a third residue and, 4. a high temperature treatment of the third residue with hydrogen to yield a final residue.
Patent NZ-509976-A (NZ)
Title: Prostate formula
Inventor: WHEELER RONALD E
IPC: A61K36/42
Filed: 1999-08-03
Abstract: A composition providing a prevention of or improvement to disorders of the prostate gland is described. The disclosure relates to a composition for the prevention of or improvement of prostatitis, and for relieving symptoms and improving objective signs of prostatitis. The formula of the composition preferably includes the following ingredients each in a therapeutically effective amount: Vitamin C, Vitamin B6, Vitamin E, zinc, glycine, L-alanine, Glutamic acid, Saw palmetto, Pygeum extract, Pumpkin seed, Stinging Nettle, Echinacea, garlic, Ginkgo leaves, and selenium.
Patent NZ-511298-A (NZ)
Title: Detection of obstacle to closing in powered furniture
Inventor: WATKINS ULLAND ISLWYN
IPC: A61G5/10
Filed: 1999-11-02
Abstract: A furniture arrangement (typically a chair or bed) powered to be movable between a first and a second configuration, including a detector arrangement (1) which detects the presence of foreign bodies in the vicinity of the furniture piece, the detector arrangement (1) being connected to a controller arranged to modify the output of the driver driving the furniture where a foreign body is detected.
Patent NZ-518002-A (NZ)
Title: Method for administering a phosphodiesterase 4 inhibitor
Inventor: MURDOCH ROBERT D
IPC: A61K/
Filed: 2000-10-26
Abstract: This invention relates to a method for increasing the dose of a PDE4 inhibitor that can be administered at one time and be tolerated by the patient by reducing the absorption rate or the rate of rise in plasma concentration of the inhibitor.
Patent NZ-518142-A (NZ)
Title: Optical determination of blood characteristics accounting for heart/limb relative height
Inventor: MILLS ALEXANDER K
IPC: A61B5/0245
Filed: 2000-10-06
Abstract: Probes having radiation emitters and detectors (98, 100, 106) are used to determine absorbance of blood within the patient's tissue to determine various blood parameters. The device also has either a position sensor (118) for determining the position of the probe with respect to the patient's heart or a movement generator for altering the position of the probe with respect to the patient's heart. In methods for non-invasively monitoring the physiological characteristics induced positional changes create differential hydrostatic pressures to facilitate measurement of blood parameters by absorbance. In a second embodiment, delays in pulse arrival times in coupled organs or members on opposite sides of the body are measured to determine cardiac output. The two methods are such that they can advantageously be used together.
Patent NZ-519285-A (NZ)
Title: Method for producing 4-(heteroaryl-methyl)-1(2H)-phthalazinones
Inventor: PETROV ORLIN
IPC: C07D403/06
Filed: 2000-12-20
Abstract: A process for the production of 4-(heteroaryl-methyl)-1(2H)-phthalazinones of general formula I in which R1 = fluorine, chlorine, bromine or hydrogen and Ar = pyridine, pyrazine or pyrimidine, characterized in that the substituted phthalidyl-3-triphenylphosphonium salts of general formula II in which R1 = fluorine, chlorine, bromine or hydrogen, are reacted with aldehydes of general formula III in which Ar = pyridine, pyrazine or pyrimidine, in the presence of a base, such as amines or alkali hydroxide or alkaline-earth hydroxides, and subsequent reaction with hydrazine hydrate and optionally under acidic conditions eg in the presence of acetic acid anhydride or acetic acid.
Patent NZ-527116-A (NZ)
Title: Decorated ear tags for domestic animals and method of making same
Inventor: JACOB TED
IPC: A01K11/00
Filed: 2002-01-08
Abstract: A decorated ear tag for livestock is disclosed that comprises a pre-printed multi-layer label bonded to a suitable tag blank to form a unitary finished tag. The resulting tag, and the information displayed thereby, are extremely resistant to deterioration by sunlight and other elements. In addition, the surface of the information panel of the resulting tag has a high slip factor that discourages obscurement of the displayed information by manure or other materials adhering to the tag.
Patent NZ-529505-A (NZ)
Title: Novel interleukin-1 and tumor necrosis factor-alpha modulators synthesis of said modulators and methods of using said modulators
Inventor: PALLADINO MICHAEL
IPC: A61P35/00
Filed: 2000-05-12
Abstract: A compound with the structure of formula I is described wherein if any R3-R5, R7, R8-, R11-R15 is not hydrogen, R2 or R6 or R9 is not methyl, or R10 is not CH2, then R1 is selected from the group consisting of hydrogen, a halogen, C1-C12 carboxylic acids, C1-C12 acyl halides, C1-C12 acyl residues, C1-C12 esters, C1-C12 secondary amides, (C1-C12)( C1-C12) tertiary amides, C1-C12 alcohols, (C1-C12)( C1-C12) ethers, C1-C12 alkyls, C1-C12 substituted alkyls, C2-C12 alkenyls, C2-C12 substituted alkenyls, and C5-C12 aryls; but if all R3-R5, R7, R8, R11-R13 are hydrogen, R2, R6 and R9 are each methyl, and R10 is CH2, then R1 is selected from hydrogen, a halogen, C1-C12 carboxylic acids, C1-C12 acyl halides, C1-C12 acyl residues, C2-C12 esters, C2-C12 secondary amides, (C1-C12)( C1-C12) tertiary amides, C2-C12 alcohols, (C1-C12)( C1-C12) ethers other than methyl-acetyl ether, C2-C12 alkyls, C1-C12 substituted alkyls, C2-C12 alkenyls, C2-C12 substituted alkenyls, and C2-C12 aryls; R2 and R9 are each separately selected from hydrogen, a halogen, C1-C12 alkyl, C1-C12 substituted alkyls, C2-C12 alkenyl, C2-C12 substituted alkenyl, C2-C12 alkynyl, C1-C12 alcohol, C1-C12 acyl, and C5-C12 aryl; R3-R5, R7, R8 and R11-R13 are each separately selected from hydrogen, a halogen, C1-C12 alkyl, C1-C12 substituted alkyls, C2-C12 alkenyl, C2-C12 substituted alkenyl, and C2-C12, alkynyl, and C5-C12 aryl;  R6 is selected from hydrogen, a halogen, C1-C12 alkyl, C1-C12 substituted alkyls, C2-C12 alkenyl, C2-C12 substited alkenyl, and C2-C12 alkynyl; R10 is selected from hydrogen, a halogen, CH2, C1-C6 alkyl, C1-C6 substituted alkyl, C2-C6 alkenyl, C2-C6 substituted alkenyl, C1-C12 alcohol, and C5-C12 aryl ; and R14 and R15 are separately selected from hydrogen, a halogen, C1-C6 alkyl, C1-C6 substituted alkyl, C2-C6 alkenyl, C2-C6 substituted alkenyl, C1-C6 alcohol, and C5-C6 aryl; The compound is disclosed to include the prodrug esters and the acid-addition salts of the above compounds. It is described to be used in the manufacture of a medicament for treating a disease condition selected from the group which includes inflammation, cancer, diabetes and cardiovascular disease.
Patent NZ-531315-A (NZ)
Title: Peptide arginals and methods for treating disseminated intravascular coagulation (DIC)
Inventor: BAJUSZ SANDOR
IPC: A61P31/04
Filed: 2002-08-21
Abstract: A compound is disclosed with the formula Xaa-Xbb-Arg-H. Xaa represents an alpha-substituted carbonic acid residue of the formula Q-CH(R)-CO wherein Q represents a 1-3 carbon alkoxycarbonylamino group, a methylamino group, or a hydroxyl group; R represents a 7-9 carbon cycloalkylmethyl group, a 1-adamanthylmethyl group, or a 5-7 carbon cycloalkyl group; and Xbb represents an L-proline or L-azetidine-2-carboxylic acid residue. Also disclosed are compounds with the structures of formula 1, 2, 3 and 4. The compounds are explained to have inhibitory action on clot-bound thrombin and factor Xa and are also inhibitory against plasmin and plasminogen activators. Therefore, the use of the peptide arginal compounds is for the manufacture of a medicament for treating a patient having disseminated intravascular coagulation.
Patent NZ-535533-A (NZ)
Title: Method for manufacture of sertindole
Inventor: ZANON JACOPO
IPC: C07D/
Filed: 2003-03-26
Abstract: Disclosed is a method for manufacture of sertindole comprising manufacturing 5-chloro-1--(4-fluorophenyl)-indole and converting it to sertindole characterised in that the method for manufacture of 5-chloro-1-(4-fluorophenyl)-indole comprises reacting 5-chloro-indole with a 4-fluorophenylhalide in the presence of a base, a chelating ligand and catalytic amounts of a copper salt comprising copper(l) or copper(ll) and an anion which does not interfere in an unfavourable way with the reaction.
Patent NZ-544738-A (NZ)
Title: System and method for using an IP address as a wireless unit identifier
Inventor: BENDER PAUL E
IPC: H04L12/56
Filed: 2004-07-15
Abstract: An access terminal comprises a transceiver means adapted for high rate packet data communications and a session information identification means for providing a location of session information for a current data communication session. The location of session information identifies a storage location external to the access terminal and an element comprising the storage location assigns the location of session information as an access terminal identifier. An apparatus for a communication session in a wireless communication system supporting Internet Protocol (JP) communications comprises a means for receiving a message from an access terminal, the message including a mobile station identifier; a means for extracting a session information IP address from the mobile station identifier; a means for requesting a session information using the session information IP address; a means for receiving the session information; and a means for processing the communication session with the access terminal. The session information IP address is assigned as the mobile station identifier by an element comprising a storage location of session information.
Patent NZ-546451-A (NZ)
Title: Erythropoietin solution formulation
Inventor: ARNOLD STEFAN
IPC: A61K38/18
Filed: 2004-12-01
Abstract: Provided is a stable pharmaceutical formulation of erythropoietin containing tris-(hydroxymethy1)-aminomethane as stabilizer, whereby the formulation does not contain amino acids or human serum albumin. Further provided are said formulations with specific buffers, pH ranges and composition proportions.
Patent NZ-547154-A (NZ)
Title: Method for the production of amino crotonyl compounds
Inventor: RALL WERNER
IPC: A61K31/517
Filed: 2004-10-12
Abstract: Disclosed is a process for preparing a compound of general formula (VII) wherein X denotes a nitrogen atom, Ra denotes a 3-chloro-4-fluorophenyl group and R3 and R4 each denote a methyl group comprising the following synthesis steps: a) reacting a compound of general formula (V) wherein X denotes a nitrogen atom and Ra denotes a 3-chloro-4-fluorophenyl group, in suitable solvents after corresponding activation with di-(C1-4-alkyl)-phosphonoacetic acid and b) reacting the resulting compound of general formula (VI) wherein X denotes a nitrogen atom, Ra denotes a 3-chloro-4-fluorophenyl group and R1 denotes a straight chain or branched C1-4-alkyl group, with the aldehyde of formula (I) wherein R3 and R4 in each case represent a methyl group, or a corresponding aldehyde equivalent using suitable organic or inorganic bases.
Patent NZ-547588-A (NZ)
Title: Antibodies that bind interleukin-4 receptor
Inventor: CARTER PAUL J
IPC: C07K16/28
Filed: 2004-11-04
Abstract: Disclosed are antibodies that bind to the IL-4 receptor and methods of making said antibodies. These antibodies are suitable for use in the treatment of diseases or conditions, including inflammatory or cancerous conditions.
Patent NZ-551414-A (NZ)
Title: Compounds containing a 1,2,3-triazolo[4,5-d]pyrimidine-7-yl radical linked to fused ring moieties for the inhibition of NAD(P)H oxidases and platelet activation
Inventor: TEGTMEIER FRANK
IPC: A61K31/4192
Filed: 2005-05-13
Abstract: Disclosed are compounds of the general Formula (I) which are useful for the inhibition of NAD(P)H oxidases (NOX) and / or for the inhibition of platelet activation, where het is a five or six-membered N-heteroaryl or a fused five or six-membered N-heteroaryl; X is S; AB is the 1,2,3-triazolo[4,5-d]pyrimidine-7-yl radical as represented by the general Formula (II); where the remaining substituents are as defined herein. Of particular importance is the compound 3-benzyl-7-(2-benzoxazolyl)thio-1,2,3-triazolo[4,5-d]pyrimidine. .
Patent NZ-553002-A (NZ)
Title: Sewage tank for use with a pump, the tank having a tapered lower portion and a plurality of intersecting ribs defining recessed pockets
Inventor: DALEY PAUL
IPC: E02D29/12
Filed: 2005-08-01
Abstract: Disclosed is a sewage tank (20) for use with a pump to convey sewage. The tank is a container (21) comprising a sidewall having an upper portion (24) and a lower tapering portion (22) defining a chamber, the lower tapering portion having a reduced size compared to said upper portion. The upper portion comprises of a plurality of intersecting ribs (25, 27) defining a plurality of recessed pockets (29), and the lower tapering portion comprises of a plurality of intersecting ribs defining a plurality of recessed pockets. Some of the recessed pockets of the lower tapering portion are defined by an outer surface of said sidewall of the lower tapering portion, and are entirely surrounded by the ribs so that the outer portions of the ribs define a plurality of openings to the recessed pockets.
Patent NZ-553901-A (NZ)
Title: Acoustical and firewall barrier assembly
Inventor: FOSTER MATTHEW
IPC: E04B1/02
Filed: 2005-08-27
Abstract: An retrofitted acoustical firewall attenuating assembly 10 comprises a frame assembly 12 having a first plate 22 extending in a first direction and having a top surface, a second plate 24 having a bottom surface spaced away from the top surface, a number of wall studs 26 spaced from one another and extending between the first plate 22 and the second plate 24, and a cement wall 16 positioned between the frame 12 and the structure and attached to the frame assembly 12 by a vibration dampener 15 made from a material selected from polymers, natural rubbers and synthetic rubbers.
Patent NZ-554528-A (NZ)
Title: Compositions for biocontrol of pathogens containing calcium salts and select Candida spp.
Inventor: PUJOS PHILIPPE
IPC: A01N37/36
Filed: 2005-09-23
Abstract: Disclosed is a composition for use against one or more pathogens, comprising at least one Candida spp selected from Candida oleophila, Candida saitoana, Candida sake, Candida tenius, or Candida utilis and at least one salt selected from calcium phosphate monobasic, calcium phosphate dibasic, calcium phosphate tribasic, calcium gulonate, calcium lactogluconate, calcium citrate, or calcium ascorbate characterised in that the amount of the salt is comprised between 0.005 and 5 g/l.
Patent NZ-567242-A (NZ)
Title: Use of an IL-21/IL-21R agonist for modulating interleukin-21 receptor activity and treating cancer
Inventor: CARRENO BEATRIZ
IPC: A61K38/20
Filed: 2002-10-04
Abstract: Use of a therapeutically effective amount of an IL-21/IL-21R agonist for the manufacture of a medicament for treating, preventing or ameliorating a cancer.
Patent NZ-585370-A (NZ)
Title: Viral polymerase inhibitors
Inventor: BEAULIEU PIERRE L
IPC: A61K31/395
Filed: 2008-12-03
Abstract: Disclosed is a carboxamide substituted phenyl pyridine ether compound of formula (I) where the substituents are as disclosed in the description. Also disclosed is a pharmaceutical composition comprising a compound of formula (I) and the use of a compound for the manufacture of a medicament for treatment of a hepatitis C viral infection (HCV).
Patent NZ-586806-A (NZ)
Title: Ultrasonic digitizer and host
Inventor: ALTMAN NATHAN
IPC: G06F3/043
Filed: 2009-01-04
Abstract: A computing system comprises a processor and internal peripheral devices, and a system bus connecting the internal peripheral devices to the processor. One of the internal peripheral devices comprises an ultrasonic digitizer configured for digitization of ultrasonic frequencies and the digitizer digitizes ultrasonic signals from at least two associated microphones into a corresponding digitized audio output and outputs the digitized audio output as a signal on the system bus.